|
|
Home >
Anti-aging Research > L-dopa
L-dopa
Related topics:
Where to purchase:
News & Research:
-
Feel-good hormone helps jog memory, finds study of seniors - Science Daily,
11/8/12 - "Half of the test participants had first taken
a placebo and the remainder had taken Levodopa. This substance, also known as
L-DOPA, is able to reach the brain from the bloodstream, and there it is
converted into dopamine ... after six hours memory performance changed. Test
subjects with Levodopa recognised up to 20 per cent more photos than the members
of the comparison group. The ratio between the amount of Levodopa taken and the
body weight of the test subjects proved to be decisive for an optimal dose"
- Yeah but I think if I remember correctly, you buildup a tolerance to Levodopa
and it no longer works.
IAS sells it.
-
Get the diet scoop: 6 promising supplements, 6 to avoid - CNN, 2/16/07 -
"promising ...
Caffeine ... EGCG
...
Chromium ... Conjugated
Linoleic Acid (CLA) ...
5-HTP ... L-dopa or
L-tyrosine"
-
New
Study Suggests Levodopa May Slow Progression Of Parkinson Disease -
Science Daily, 12/24/04
- L-Dopa Doesn't
Hasten Parkinson's Disease - WebMD, 12/8/04
-
Parcopa (Carbidopa-Levodopa) Orally Dissolving Tablets for Parkinson's
Disease Now Available in US - Doctor's Guide, 9/27/04
-
Levodopa And Pramipexole Both Appear To Be Reasonable Options For Initial
Treatment Of Parkinson Disease - Doctor's Guide, 7/19/04
-
Enteral Carbidopa/Levodopa (Duodopa) Alleviates Motor Symptoms, "Off" Times
in Parkinson's Disease - Doctor's Guide, 6/21/04
- Elevated Homocysteine
Associated With Levodopa, Peripheral Nerve Dysfunction in Parkinson's
Disease - Medscape, 5/18/04
-
Levodopa-induced Dyskinesias Relieved With Anti-epileptics - Doctor's
Guide, 4/30/04
-
Levodopa Medications Do Not Improve Parkinsonian Speech - Doctor's
Guide, 4/30/04
-
Adjunctive Therapy With Levodopa May Be Beneficial in Patients with
Schizophrenia - Doctor's Guide, 3/9/04
- Levodopa May Be
Addictive - WebMD, 11/24/03
-
Rasagiline Plus Levodopa Improves Control Of Parkinson Disease Symptoms
- Doctor's Guide, 9/4/03
-
FDA Approves Stalevo (Carbidopa, Levodopa, Entacapone) For Treatment Of
Parkinson's Disease - Doctor's Guide, 6/13/03
-
Early Levodopa Seems To Slow Parkinson's - Clinical Psychiatry News,
5/03
-
Piribedil Combined with Levodopa Improves Motor Symptoms in Parkinson's
Disease Nonfluctuating Patients - Doctor's Guide, 4/25/03
-
Levodopa Treatment Not Associated with Accelerated Progression in
Parkinson's Disease - Doctor's Guide, 4/3/03
- Levodopa Does Not
Hasten Clinical Parkinson's Progression - Medscape, 4/2/03
-
Concern About Long-Term Levodopa Use in Parkinson's Patients is Unfounded
- Doctor's Guide, 10/17/02
- Expert Panel
Finds SAMe Promising - WebMD, 10/10/02 -
"The L-dopa medication that patients take for
Parkinson's makes them unusually
SAMe-deficient "because L-dopa consumes vast
quantities of SAMe, like a sponge, it mops up all the SAMe in the body."
- See
iHerb and
Vitacost
SAMe products.
-
Entacapone May Help Prolong Levodopa's Effect On Parkinson's Disease -
Doctor's Guide, 4/19/02
-
Excessive Hand Force in Parkinson's Disease with Levodopa-Induced
Dyskinesias - Doctor's Guide, 4/16/02
-
Imaging Marker Detects Parkinson's Degeneration - Doctor's Guide, 4/3/02
- New Parkinson's
Drug Saves Brain Cells - WebMD, 4/2/02
-
Alleviating Interdose Trough Disability Could Prolong Levadopa's Effects in
Parkinson's - Doctor's Guide, 12/6/01
- Late Levodopa Does Not
Bring on Dyskinesias More Rapidly After Ropinirole Monotherapy For
Parkinson's - Doctor's Guide, 8/3/01
- Levodopa Uptake Not
Impaired by Normal Protein Diet - Doctor's Guide, 8/1/01
- Comtan/Comtess
(Entacapone) May Reduce Severity Of Levodopa Complications - Doctor's
Guide, 7/30/01
- Levodopa Slows The
Progression Of Parkinson's Disease - Doctor's Guide, 5/28/99
- Levodopa May Improve
Attention Deficit Symptoms - Doctor's Guide, 4/30/98
Abstracts:
-
Elevated Plasma Homocysteine Levels in Patients Treated With Levodopa:
Association With Vascular Disease - Archives of Neurology, 1/03 -
"Levodopa therapy, rather than PD, is a cause of
hyperhomocysteinemia in patients with PD. Deficiency of folate or vitamin
B12 levels does not explain the elevated homocysteine levels in these
patients"
-
Parenteral application of NADH in Parkinson's disease: clinical improvement
partially due to stimulation of endogenous levodopa biosynthesis - J
Neural Transm. 1996;103(10):1187-93 - "In conclusion
NADH in used galenic form may be a potent stimulator of endogenous
levodopa biosynthesis with clinical benefit for Parkinsonian patients."
|
|